First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies Meeting Abstract
| Authors: | Harding, J. J.; Awada, A.; Decaens, T.; Roth, G.; Merle, P.; Kotecki, N.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Mezouar, S.; Menut, A.; Bestion, E.; Paradis, V.; Halfon, P.; Raymond, E.; Abou-Alfa, G. K. |
| Abstract Title: | First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120302102 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.e16175 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e16175 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work